Source: Annual Congress 2009 - Methodological aspects of asthma and COPD epidemiology
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Olivieri, M. Braggion, S. Accordini, C. Bombieri, O. Bortolami, V. Cappa, L. Cazzoletti, L. Cazzoletti, J. D‘Amato, M. Ferrari, A. Ganassini, P. Girardi, V. Lo Cascio, F. Locatelli, A. Marcon, M. Nicolis, P. F. Pignatti, L. Perbellini, A. Poli, M. Rava, S. Sembeni, E. Trabetti, G. Verlato, M. E. Zanolin, R. De Marco (Verona, Italy). Ability of different flow rates of fractional exhaled nitric oxide (FeNO) to discriminate between asthmatic and non asthmatic subjects. Eur Respir J 2009; 34: Suppl. 53, 1013

Member's Comments

No comment yet.

Related content which might interest you: Fractional exhaled nitric oxide (FeNO) in asthmatic children and their parents Source: Eur Respir J 2006; 28: Suppl. 50, 270s Year: 2006 Normal values fro fraction of exhaled nitric oxide (FENO) among non-smoking adults Source: Eur Respir J 2004; 24: Suppl. 48, 267s Year: 2004 Usefulness of fractional exhaled nitric oxide (FeNO) as a marker of asthma control Source: Annual Congress 2008 - Phenotyping of asthma and COPD Year: 2008 Reproducibility of exhaled nitric oxide measurements in healthy and asthmatic adults and children Source: Eur Respir J 2003; 21: 433-438 Year: 2003 Determination of exhaled nitric oxide in healthy volunteers and asthmatic patients: comparison of two devices Source: Eur Respir J 2006; 28: Suppl. 50, 791s Year: 2006 Exhaled nitric oxide fraction in asthmatic children: relationship with spirometric patterns and spirometric response to exercise Source: International Congress 2018 – Paediatric asthma: new mechanisms and tools Year: 2018 FeNO (fractional exhaled nitric oxide) measurements in pregnant asthmatic women. The long-term, intra-subject variability of FeNO in controlled asthma Source: Annual Congress 2012 - Exhaled biomarkers in airway diseases Year: 2012 Comparisons for concentration in exhaled nitric oxide between patients with bronchial asthma and COPD Source: Annual Congress 2007 - Pathophysiology and assessment of COPD Year: 2007 Gender differences in exhaled nitric oxide concentrations (FeNO) in healthy individuals Source: Eur Respir J 2001; 18: Suppl. 33, 258s Year: 2001 The influence of spirometry on the level of exhaled nitric oxide in asthmatic children Source: Eur Respir J 2003; 22: Suppl. 45, 569s Year: 2003 Fractal-type long-range correlations in exhaled nitric oxide levels in asthmatic children Source: Annual Congress 2008 - Respiratory physiology in health and disease Year: 2008 Reproducibility of exhaled nitric oxide (FENO) measurements in healthy subjects Source: Eur Respir J 2004; 24: Suppl. 48, 681s Year: 2004 Fractional exhaled nitric oxide (FeNO) for an early diagnosis of asthma Source: Eur Respir J 2006; 28: Suppl. 50, 677s Year: 2006 Comparison of three different exhaled nitric oxide analyzers in asthma and COPD Source: International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification Year: 2019 Relationship between exhaled nitric oxide (eNO) and sputum eosinophils in severe asthma Source: Eur Respir J 2004; 24: Suppl. 48, 596s Year: 2004 Exhaled nitric oxide (eNO) levels in asthmatic children: relation to atopy and airway responsiveness (AHR) Source: Eur Respir J 2004; 24: Suppl. 48, 271s Year: 2004 Concentrations of nitric oxide metabolites in the exhaled breath condensate in children with different bronchial asthma control Source: Annual Congress 2012 - Exhaled biomarkers in airway diseases Year: 2012 Comparison of asthma control test and exhaled nitric oxide to predict asthma control Source: Annual Congress 2010 - Asthma: breath biomarkers and asthma control Year: 2010 Relationship between exhaled nitric oxide (eNO), atopy and asthma in children. ISAAC-clermont-ferrand Source: Eur Respir J 2001; 18: Suppl. 33, 38s Year: 2001 Relationship between baseline fraction of exhaled nitric oxide (FeNO) and response to anti-IL-5/5R therapies in severe eosinophilic asthma (SEA) Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma Year: 2020